Advertisement
EJVES Extra Abstracts| Volume 34, ISSUE 2, P249, August 2007

Endovascular Treatment of Femoral Artery Pseudoaneurysm in a HIV Positive Patient – A Case Report

Open ArchivePublished:May 10, 2007DOI:https://doi.org/10.1016/j.ejvs.2007.02.012
      Arterial pseudoaneurysm formation has been increasingly reported in HIV positive patients and generally surgery is indicated. We paced an endovascular stent in a femoral artery pseudoaneurysm of a 30-year-old HIV-positive male. Early results of this procedure are good. We believe that implantation of an endovascular stent graft can result in a shorter hospital stay and can significantly reduce morbidity for HIV-positive patients with pseudoaneurysms.

      Linked Article

      • Endovascular Treatment of Femoral Artery Pseudoaneurysm in a HIV Positive Patient – A Case Report
        EJVES ExtraVol. 13Issue 6
        • Preview
          Arterial pseudoaneurysm formation has been increasingly reported in HIV positive patients and generally surgery is indicated. We paced an endovascular stent in a femoral artery pseudoaneurysm of a 30-year-old HIV-positive male. Early results of this procedure are good. We believe that implantation of an endovascular stent graft can result in a shorter hospital stay and can significantly reduce morbidity for HIV-positive patients with pseudoaneurysms.
        • Full-Text
        • PDF
        Open Access

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.